Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)

• Status: Completed
• Trial end date: 2007-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This study was designed to determine if the investigational drug is effective and safe in individuals with COPD (chronic pulmonary disease)

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Cilomilast

Criteria

Inclusion criteria:

• Diagnosis of COPD and a history of cigarette smoking.

Exclusion criteria:

• Significant heart or lung disease not associated with COPD.

• Significant stomach or intestinal disease.